|
36 Companies |
|
44 Products |
|
44 Products |
|
65 Mechanisms of Action |
|
1 Trial |
|
600 News |
|
| 12345678910111213» |
- | NN1213 / Novo Nordisk
Trial completion, MRI: Intracoronary Thrombus Detection by Magnetic Resonance Imaging (clinicaltrials.gov) - Jun 21, 2024
P=N/A, N=40, Completed, Sponsor: University of Edinburgh
Suspended --> Completed
- | Phase classification: RESCUE: Randomized Evaluation of Patients With Stable Angina Comparing Diagnostic Examinations (clinicaltrials.gov) - Dec 25, 2023
P=N/A, N=1050, Terminated, Sponsor: American College of Radiology
Suspended --> Completed Phase classification: P3 --> P=N/A
- | ticagrelor / Generic mfg.
Enrollment change: Impact of Ticagrelor on the Endothelial Healing Following Drug-eluting Stent Implantation in the Patients With Acute Coronary Syndrome (clinicaltrials.gov) - Apr 19, 2019
P4, N=148, Terminated, Sponsor: Yonsei University
Phase classification: P3 --> P=N/A N=444 --> 148
- | NN1213 / Novo Nordisk
Trial completion: Drug Coated Balloon Compared to Bare Metal Stent for de Novo Coronary Artery Lesions (clinicaltrials.gov) - Apr 3, 2019
P=N/A, N=40, Completed, Sponsor: Ulsan University Hospital
N=444 --> 148 Recruiting --> Completed
- ||| NN1213 / Novo Nordisk
Trial completion: MAGNET-ACS: VitalScan MCG Rule-out Multi-centre Pivotal Study - UK (clinicaltrials.gov) - Apr 3, 2019
P=N/A, N=756, Completed, Sponsor: Creavo Medical Technologies Ltd
Recruiting --> Completed Active, not recruiting --> Completed
- | ticagrelor / Generic mfg., morphine sulphate / Generic mfg.
Trial completion, Trial completion date, Trial primary completion date: Influence of Metoclopramide on Ticagrelor Pharmacokinetics and Pharmacodynamics in Patients With Unstable Angina Pectoris on Concomitant Treatment With Morphine (clinicaltrials.gov) - Apr 1, 2019
P4, N=32, Completed, Sponsor: Collegium Medicum w Bydgoszczy
Active, not recruiting --> Completed Recruiting --> Completed | Trial completion date: Sep 2017 --> Dec 2017 | Trial primary completion date: Sep 2017 --> Dec 2017
- | ticagrelor / Generic mfg., morphine sulphate / Generic mfg.
Trial completion, Trial completion date, Trial primary completion date: Influence of Naloxone on Ticagrelor Pharmacokinetics and Pharmacodynamics in Patients With Unstable Angina Pectoris on Concomitant Treatment With Morphine (clinicaltrials.gov) - Apr 1, 2019
P4, N=30, Completed, Sponsor: Collegium Medicum w Bydgoszczy
Recruiting --> Completed | Trial completion date: Sep 2017 --> Dec 2017 | Trial primary completion date: Sep 2017 --> Dec 2017 Recruiting --> Completed | Trial completion date: Sep 2017 --> Dec 2018 | Trial primary completion date: Sep 2017 --> Dec 2018
- | NN1213 / Novo Nordisk
Trial completion date, Trial primary completion date, HEOR: FFR-SELECT: Routine Versus Selective Use of FFR to Guide PCI (clinicaltrials.gov) - Feb 26, 2019
P4, N=261, Terminated, Sponsor: Cardiology Research UBC
Recruiting --> Completed | Trial completion date: Sep 2017 --> Dec 2018 | Trial primary completion date: Sep 2017 --> Dec 2018 Trial completion date: Apr 2016 --> Feb 2017 | Trial primary completion date: Apr 2015 --> Feb 2017
- | NN1213 / Novo Nordisk
Trial completion, Enrollment change: The FOVUS-ER Study: Focused Vascular Ultrasound to Risk Stratify Patients With Chest Pain in the ER (clinicaltrials.gov) - Jan 23, 2019
P=N/A, N=326, Completed, Sponsor: Queen's University
Trial completion date: Apr 2016 --> Feb 2017 | Trial primary completion date: Apr 2015 --> Feb 2017 Recruiting --> Completed | N=500 --> 326
- | Trial completion, Trial completion date, Trial primary completion date: OUT-ACS: One-hour Troponin in a Low-prevalence Population of Acute Coronary Syndrome (clinicaltrials.gov) - Jan 17, 2019
P=N/A, N=1750, Completed, Sponsor: Oslo University Hospital
Recruiting --> Completed | N=500 --> 326 Recruiting --> Completed | Trial completion date: Dec 2017 --> Oct 2018 | Trial primary completion date: Dec 2017 --> Oct 2018
- | Trial completion, Phase classification: NORSTENT: Trial of Drug Eluting Stent Versus Bare Metal Stent to Treat Coronary Artery Stenosis (clinicaltrials.gov) - Dec 24, 2018
P=N/A, N=9013, Completed, Sponsor: University of Tromso
Recruiting --> Completed | Trial completion date: Dec 2017 --> Oct 2018 | Trial primary completion date: Dec 2017 --> Oct 2018 Active, not recruiting --> Completed | Phase classification: P4 --> PN/A
- || NN1213 / Novo Nordisk
Trial completion date, Trial primary completion date: MAGNET-ACS: VitalScan MCG Rule-out Multi-centre Pivotal Study - UK (clinicaltrials.gov) - Dec 21, 2018
P=N/A, N=756, Active, not recruiting, Sponsor: Creavo Medical Technologies Ltd
Active, not recruiting --> Completed | Phase classification: P4 --> PN/A Trial completion date: Aug 2018 --> Feb 2019 | Trial primary completion date: Apr 2018 --> Dec 2018
- | NN1213 / Novo Nordisk
Trial completion date: FEASTRU: Feasibility and Outcomes of Complete Coronary Revascularization Using BVS in All-comer Patients With Angina (clinicaltrials.gov) - Dec 13, 2018
P=N/A, N=1602, Completed, Sponsor: International Foundation for Development of Medical Science and Education Healthy Heart
Trial completion date: Aug 2018 --> Feb 2019 | Trial primary completion date: Apr 2018 --> Dec 2018 Trial completion date: Jul 2017 --> Jul 2018
- | ticagrelor / Generic mfg., clopidogrel / Generic mfg.
Trial completion, Trial completion date, Trial primary completion date: TICA KOREA: Safety and Efficacy of Ticagrelor Versus Clopidogrel in Asian/KOREAn Patients With Acute Coronary Syndromes Intended for Invasive Management (clinicaltrials.gov) - Nov 30, 2018
P4, N=800, Completed, Sponsor: Seung-Jung Park
Trial completion date: Jul 2017 --> Jul 2018 Active, not recruiting --> Completed | Trial completion date: Jun 2020 --> Nov 2018 | Trial primary completion date: Jan 2020 --> Nov 2018
- | Kengreal (cangrelor) / Chiesi
Trial completion, Trial completion date, Trial primary completion date: The Effect of IV Cangrelor and Oral Ticagrelor Study (clinicaltrials.gov) - Oct 31, 2018
P4, N=100, Completed, Sponsor: The Royal Wolverhampton Hospitals NHS Trust
Active, not recruiting --> Completed | Trial completion date: Jun 2020 --> Nov 2018 | Trial primary completion date: Jan 2020 --> Nov 2018 Recruiting --> Completed | Trial completion date: Feb 2019 --> Oct 2018 | Trial primary completion date: Feb 2018 --> Oct 2018
- | Xience (everolimus-eluting stent) / Abbott
Trial completion: BIOSCIENCE: Sirolimus-eluting Stents With Biodegradable Polymer Versus an Everolimus-eluting Stents (clinicaltrials.gov) - Oct 18, 2018
P=N/A, N=2119, Completed, Sponsor: University Hospital Inselspital, Berne
Recruiting --> Completed | Trial completion date: Feb 2019 --> Oct 2018 | Trial primary completion date: Feb 2018 --> Oct 2018 Active, not recruiting --> Completed
- | NN1213 / Novo Nordisk
Trial completion, Trial primary completion date: NOVA-SKIN: Novel Vitality Indices Derived From the Hexoskin in Patients Affected With Angina Undergoing Coronary Revascularization or Medical Therapy (clinicaltrials.gov) - Oct 5, 2018
P=N/A, N=30, Completed, Sponsor: Montreal Heart Institute
Active, not recruiting --> Completed Recruiting --> Completed | Trial primary completion date: Apr 2018 --> Jul 2018
- | Lexiscan (regadenoson) / GE Healthcare, Astellas, Gilead
Phase classification, Enrollment change: Comparison of Dobutamine and Regadenoson Stress Cardiac Magnetic Resonance (MR) (clinicaltrials.gov) - Sep 26, 2018
P1, N=14, Terminated, Sponsor: Wake Forest University Health Sciences
Recruiting --> Completed | Trial primary completion date: Apr 2018 --> Jul 2018 Phase classification: P4 --> P1 | N=40 --> 14
- | ivabradine / Generic mfg.
Enrollment change, Trial completion date, Trial withdrawal, Trial primary completion date: MICRO-PCI: Ivabradine and Post-revascularisation Microcirculatory Dysfunction (clinicaltrials.gov) - Aug 17, 2018
P4, N=0, Withdrawn, Sponsor: Liverpool Heart and Chest Hospital NHS Foundation Trust
Phase classification: P4 --> P1 | N=40 --> 14 N=75 --> 0 | Suspended --> Withdrawn | Trial completion date: Feb 2018 --> Mar 2016 | Trial primary completion date: Feb 2018 --> Mar 2016
- | Trial completion: eCOBRA: Safety and Effectiveness Evaluation of COBRA PzF Coronary Stent System: A Post Marketing Observational Registry (clinicaltrials.gov) - Aug 7, 2018
P=N/A, N=1027, Completed, Sponsor: CeloNova BioSciences, Inc.
N=75 --> 0 | Suspended --> Withdrawn | Trial completion date: Feb 2018 --> Mar 2016 | Trial primary completion date: Feb 2018 --> Mar 2016 Active, not recruiting --> Completed
- | ticagrelor / Generic mfg., aspirin / Generic mfg.
Enrollment change, Trial completion date, Trial termination, Trial primary completion date: TiCAB: Study Comparing Ticagrelor With Aspirin for Prevention of Vascular Events in Patients Undergoing CABG (clinicaltrials.gov) - Aug 2, 2018
P3, N=1893, Terminated, Sponsor: Deutsches Herzzentrum Muenchen
Active, not recruiting --> Completed N=3850 --> 1893 | Trial completion date: Apr 2020 --> May 2018 | Recruiting --> Terminated | Trial primary completion date: Dec 2019 --> May 2018; DSMB Interim Analyses
- | NN1213 / Novo Nordisk
Trial completion, Enrollment change, Trial completion date, Trial primary completion date: FEASTRU: Feasibility and Outcomes of Complete Coronary Revascularization Using BVS in All-comer Patients With Angina (clinicaltrials.gov) - Aug 2, 2018
P=N/A, N=1602, Completed, Sponsor: International Foundation for Development of Medical Science and Education Healthy Heart
N=3850 --> 1893 | Trial completion date: Apr 2020 --> May 2018 | Recruiting --> Terminated | Trial primary completion date: Dec 2019 --> May 2018; DSMB Interim Analyses Recruiting --> Completed | N=2500 --> 1602 | Trial completion date: Aug 2020 --> Jul 2017 | Trial primary completion date: Dec 2017 --> Jun 2017
- | NN1213 / Novo Nordisk
Enrollment closed: MAGNET-ACS: VitalScan MCG Rule-out Multi-centre Pivotal Study - UK (clinicaltrials.gov) - Jul 19, 2018
P=N/A, N=756, Active, not recruiting, Sponsor: Creavo Medical Technologies Ltd
Recruiting --> Completed | N=2500 --> 1602 | Trial completion date: Aug 2020 --> Jul 2017 | Trial primary completion date: Dec 2017 --> Jun 2017 Recruiting --> Active, not recruiting
- | Victoza (liraglutide) / Novo Nordisk, NN1213 / Novo Nordisk
Trial completion: GAP: Glucagon-like Peptide-1 and Coronary Microvascular Dysfunction in Women With Angina Pectoris and no Coronary Stenosis (clinicaltrials.gov) - Jul 11, 2018
P4, N=33, Completed, Sponsor: Eva Prescott
Recruiting --> Active, not recruiting Recruiting --> Completed
- | NN1213 / Novo Nordisk, Xience (everolimus-eluting stent) / Abbott
Trial completion, Trial completion date, Trial primary completion date: BVS-Flow: Comparison of the Vasomotor Function and Myocardial Flow in Patients Treated With Bioresorbable and Metallic Stents at 1 Year (clinicaltrials.gov) - Jul 3, 2018
P4, N=70, Completed, Sponsor: Institut d'Investigaci
Recruiting --> Completed Active, not recruiting --> Completed | Trial completion date: Mar 2018 --> Jul 2018 | Trial primary completion date: Mar 2018 --> Jul 2018
- | NN1213 / Novo Nordisk
Trial completion: FUTURE: Functional Testing Underlying Coronary Revascularisation (clinicaltrials.gov) - Jun 26, 2018
P=N/A, N=941, Completed, Sponsor: Hospices Civils de Lyon
Active, not recruiting --> Completed | Trial completion date: Mar 2018 --> Jul 2018 | Trial primary completion date: Mar 2018 --> Jul 2018 Active, not recruiting --> Completed
- | sirolimus / Generic mfg.
Phase classification: Optical Coherence Tomography Comparison of Neointimal Coverage Between CRE8 DES and BMS (clinicaltrials.gov) - Apr 30, 2018
P=N/A, N=38, Completed, Sponsor: CID - Carbostent & Implantable Devices
Active, not recruiting --> Completed Phase classification: P4 --> P=N/A
- ||| Trial completion, Phase classification: International Randomized Comparison Between DES Limus Carbostent and Taxus DES in the Treatment of De-novo Coronary Lesions (clinicaltrials.gov) - Apr 30, 2018
P=N/A, N=323, Completed, Sponsor: CID - Carbostent & Implantable Devices
Phase classification: P4 --> P=N/A Active, not recruiting --> Completed | Phase classification: P3 --> PN/A
- | Trial completion, Surgery: Registry of Non-primary Angioplasty at Hospitals Without Surgery On-site (clinicaltrials.gov) - Apr 12, 2018
P=N/A, N=31390, Completed, Sponsor: Johns Hopkins University
Active, not recruiting --> Completed | Phase classification: P3 --> PN/A Recruiting --> Completed
- | Trial completion date, Trial primary completion date: BASIC VALIDATE Coronary Stent Registry (clinicaltrials.gov) - Apr 11, 2018
P=N/A, N=0, Withdrawn, Sponsor: Region
Recruiting --> Completed Trial completion date: Jul 2021 --> Apr 2018 | Trial primary completion date: Jun 2021 --> Apr 2018
- ||||||| Trial completion, Trial completion date, Trial primary completion date: Efficacy of Extracorporeal Shockwave Myocardial Revascularization Therapy in Patients With Stable Angina Pectoris (clinicaltrials.gov) - Apr 10, 2018
P3, N=72, Completed, Sponsor: Evgeny Shkolnik, MD
Trial completion date: Jul 2021 --> Apr 2018 | Trial primary completion date: Jun 2021 --> Apr 2018 Recruiting --> Completed | Trial completion date: Sep 2016 --> Dec 2017 | Trial primary completion date: Jun 2016 --> Dec 2017
- | Enrollment open, Trial completion date, Trial primary completion date: The FOVUS-ER Study: Focused Vascular Ultrasound to Risk Stratify Patients With Chest Pain in the ER (clinicaltrials.gov) - Apr 9, 2018
P=N/A, N=500, Recruiting, Sponsor: Queen's University
Recruiting --> Completed | Trial completion date: Sep 2016 --> Dec 2017 | Trial primary completion date: Jun 2016 --> Dec 2017 Not yet recruiting --> Recruiting | Trial completion date: Jan 2018 --> Jan 2019 | Trial primary completion date: Nov 2017 --> Nov 2018
- || Phase classification: MAGNET-ACS: VitalScan MCG Rule-out Multi-centre Pivotal Study - UK (clinicaltrials.gov) - Mar 30, 2018
P, N=756, Recruiting, Sponsor: Creavo Medical Technologies Ltd
Not yet recruiting --> Recruiting | Trial completion date: Jan 2018 --> Jan 2019 | Trial primary completion date: Nov 2017 --> Nov 2018 Phase classification: P=N/A --> P
- Aggrastat (tirofiban) / Correvio, Medicure
Enrollment change, Trial withdrawal: ATLAST-PCI: Aggrastat Truncated Length Against Standard Therapies in Percutaneous Coronary Intervention (clinicaltrials.gov) - Mar 13, 2018
P3, N=0, Withdrawn, Sponsor: Medicure
Phase classification: P=N/A --> P N=1900 --> 0 | Suspended --> Withdrawn
- | Trial completion: Improving Intermediate Risk Management. MARK Study (clinicaltrials.gov) - Mar 9, 2018
P=N/A, N=2495, Completed, Sponsor: Jordi Gol i Gurina Foundation
N=1900 --> 0 | Suspended --> Withdrawn Active, not recruiting --> Completed
- | Trial completion, Gene therapy: KAT301: EndocardialVascularEndothelialGrowth Factor D(VEGF-D)Gene Therapy for the Treatment of Severe Coronary Heart Disease (clinicaltrials.gov) - Mar 8, 2018
P1, N=30, Completed, Sponsor: Kuopio University Hospital
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | aspirin / Generic mfg.
Phase classification: Aspirin Resistance and Percutaneous Coronary Intervention (PCI) (clinicaltrials.gov) - Feb 14, 2018
P2, N=36, Completed, Sponsor: Icahn School of Medicine at Mount Sinai
Active, not recruiting --> Completed Phase classification: P=N/A --> P2
- |||| Trial primary completion date: Efficacy and Safety Study of Total Flavonoids of Propolis Dropping Pill to Treat Angina Pectoris (clinicaltrials.gov) - Feb 7, 2018
P3, N=478, Completed, Sponsor: Shanghai Greenvalley Pharmaceutical Co., Ltd.
Phase classification: P=N/A --> P2 Trial primary completion date: Aug 2012 --> Jun 2014
- || Trial completion date, Trial primary completion date: MAGNET-ACS: VitalScan MCG Rule-out Multi-centre Pivotal Study - UK (clinicaltrials.gov) - Feb 5, 2018
P=N/A, N=756, Recruiting, Sponsor: Creavo Medical Technologies Ltd
Trial primary completion date: Aug 2012 --> Jun 2014 Trial primary completion date: Sep 2017 --> Mar 2018 | Trial completion date: May 2018 --> Jul 2018
- | Enrollment change, Trial primary completion date, Head-to-Head: Drug-Eluting Balloon in Stable and Unstable Angina (clinicaltrials.gov) - Jan 30, 2018
P=N/A, N=220, Terminated, Sponsor: North Karelia Central Hospital
Trial primary completion date: Sep 2017 --> Mar 2018 | Trial completion date: May 2018 --> Jul 2018 N=600 --> 220 | Trial primary completion date: Dec 2015 --> Jan 2018
- | Trial completion, Enrollment change: Usefulness of a 2-hour Delta Troponin-I During the ED Identification and Exclusion of Acute Myocardial Infarction (clinicaltrials.gov) - Jan 24, 2018
P=N/A, N=240, Completed, Sponsor: Chattanooga-Hamilton County Hospital Authority
N=600 --> 220 | Trial primary completion date: Dec 2015 --> Jan 2018 Active, not recruiting --> Completed | N=1000 --> 240
- | Trial primary completion date: NOVA-SKIN: Novel Vitality Indices Derived From the Hexoskin in Patients Affected With Angina Undergoing Coronary Revascularization or Medical Therapy (clinicaltrials.gov) - Jan 18, 2018
P=N/A, N=30, Recruiting, Sponsor: Montreal Heart Institute
Active, not recruiting --> Completed | N=1000 --> 240 Trial primary completion date: Dec 2017 --> Apr 2018
- | ranolazine ER / Generic mfg.
Enrollment change, Trial primary completion date: RWISE: Treatment With Ranolazine in Microvascular Coronary Dysfunction (MCD): Impact on Angina Myocardial Ischemia (clinicaltrials.gov) - Dec 19, 2017
P=N/A, N=142, Completed, Sponsor: Cedars-Sinai Medical Center
Trial primary completion date: Dec 2017 --> Apr 2018 N=101 --> 142 | Trial primary completion date: Jun 2016 --> Dec 2016
- | Trial completion: DETO2X-AMI: An Efficacy and Outcome Study of Supplemental Oxygen Treatment in Patients With Suspected Myocardial Infarction (clinicaltrials.gov) - Dec 11, 2017
P3, N=6629, Completed, Sponsor: Karolinska Institutet
N=101 --> 142 | Trial primary completion date: Jun 2016 --> Dec 2016 Active, not recruiting --> Completed
- | Biomarker, Trial completion: DETO2X-bio: Determination of the Role of Oxygen in Suspected Acute Myocardial Infarction by Biomarkers (clinicaltrials.gov) - Dec 11, 2017
P3, N=175, Completed, Sponsor: Karolinska Institutet
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: Danhong Injection in the Treatment of Unstable Angina Pectoris (clinicaltrials.gov) - Dec 2, 2017
P4, N=160, Completed, Sponsor: China Academy of Chinese Medical Sciences
Active, not recruiting --> Completed Recruiting --> Completed
- | Trial completion: BRAINHEART: Brain-heart Interactions in Tako-Tsubo Cardiomyopathy and Cardiac Syndrome X: (clinicaltrials.gov) - Nov 22, 2017
P=N/A, N=50, Completed, Sponsor: Ospedale San Giovanni Bellinzona
Recruiting --> Completed Recruiting --> Completed
- | Trial completion: Acute Episodes in Chronic Stable Angina: Assessment of the Use of the Coronary Vasodilator Propatyl Nitrate. (clinicaltrials.gov) - Oct 26, 2017
P4, N=200, Completed, Sponsor: Funda
Recruiting --> Completed Active, not recruiting --> Completed
- ||| Trial completion, Enrollment change: BIOFLOW III Satellite-Italy Orsiro Stent System (clinicaltrials.gov) - Oct 2, 2017
P=N/A, N=609, Completed, Sponsor: Biotronik Italia S.p.A.
Active, not recruiting --> Completed Active, not recruiting --> Completed | N=500 --> 609
- | Trial completion, Enrollment change, Trial primary completion date: RegentVsel: Intracardiac CD133+ Cells in Patients With No-option Resistant Angina (clinicaltrials.gov) - Sep 28, 2017
P2, N=31, Completed, Sponsor: Medical University of Silesia
Active, not recruiting --> Completed | N=500 --> 609 Recruiting --> Completed | N=60 --> 31 | Trial primary completion date: Dec 2016 --> Sep 2016